List view / Grid view
Human milk oligosaccharides are the third most abundant component of human milk after lactose and lipids, reaching between 5 and 20 g/L in mature human milk.
Dr Katja Parschat explains how biotechnology-derived complex oligosaccharides inhibit the binding of norovirus to its natural receptors.
The pathogenesis of autoimmune diseases is not completely understood, but environmental factors such as life-style, diet, drugs, and infections are thought to be involved.
Dr. Evelyn Jantscher-Krenn is a well-known researcher and specialist in the field of human milk oligosaccharides, glycobiology, pregnancy and placenta.
Jennewein Biotechnolgie produces human milk oligosaccharides (HMOs), which are functional sugars.
HMO’s are special sugars that play a crucial role in baby’s development. With biotechnological processes they can be produced on industrial scale.
Jennewein Biotechnologie discusses the importance of adding human milk oligosaccharides (HMOs) to infant formula to better emulate the benefits of breast milk.
Jennewein Biotechnologie and Yili Group join forces for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market.
Our Dairy In-Depth Focus features Dr Maryanne Drake of North Carolina State University as she explores reducing sugar techniques in products such as ice cream, yoghurt, and flavoured milk.
Jennewein Biotechnologie discusses the importance of human milk oligosaccharides (HMOs) in reducing the likelihood of children developing allergies.
How the microbiome develops during childhood has repercussions for the rest of our lives. It influences our risk of developing allergies, intestinal illnesses and becoming overweight. Nutrition plays an important role from the outset. Polysaccharides in breast milk – human milk oligosaccharides (HMO) – can promote a healthy intestinal flora.
